Company: STAA
Filing Date: 2025-09-26
Form Type: 8-K
Source: 0001193125-25-218827
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-09-26
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01. Regulation FD Disclosure.

On September 26, 2025, STAAR Surgical Company, a Delaware corporation (the “ Company”), issued an investor presentation discussing highlighted reasons why the proposed merger with Alcon maximizes value for Company stockholders, and issued a related press release. A copy of such investor presentation and press release are furnished as Exhibits 99.1 and 99.2 to this Current Report, respectively, and are incorporated herein by reference.

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.